Promomed
TypeLimited liability company
Industry
Founded2005 (2005) in Moscow
FoundersPetr Bely
Headquarters
Moscow
,
Russia
Area served
Russia & Worldwide [1]
Key people
Petr Bely (CEO)
Products
Websitepromomed.ru/en/ >

Promomed Group is a Russian pharmaceutical company specialising in elaboration, production, check studies and distribution of medicinal drugs. Its major production site, the Biokhimik Plant, is in Saransk.

History

The Promomed Group was established in 2005. It was planned, from the outset, that the company would be carrying out clinical trials as well as exercising promotional marketing of pharmaceuticals made to order.[2] as its first pharmaceutical drug.[2]

In 2007, the company launched Reduxin, a drug to treat obesity.[3]

In 2012, the Promomed Group, in cooperation with National Medical Research Center for Endocrinology (Russia) and Russian Association of Endocrinologists, initiated a world's largest observational study that covered 100 000 patients and 3 000 doctors in 142 locations around Russia.[4][5]

In 2015, Promomed acquired the Biokhimik plant; that same year an updated work unit got underway at the plant, to produce lozenges and capsules.[6][7][8]

Still in 2017 and for the first time in Russia, full-cycle production, from a strain variant to the finished product, of an antibiotic substance, Vancomycin, was developed and put in working order.[9]

In 2018, the Company opened its Representative office in Vietnam.[10]

In 2020, Promomed Group obtained approval for production and marketing of areplivir, a drug developed on the basis of favipiravir molecule for the treatment of COVID-19.[11][12] That same year, the Company placed its bonds on the Moscow Exchange, with a total value of 1 billion rubles (next placements in 2021 - 5 billion rubles and in 2022 - 2,5 billion rubles).[13][14][15][16]

In 2023, Promomed Group bought a controlling stake in pharmaceutical company Berakhim.[17]

Activities

Promomed Group is engaged in production of endocrinological, rheumatological, neurological, antiviral, antibacterial, antitumor and other types of drugs.[18][4]

The company's portfolio contained over 180 various names of drugs in 2021 and 80 percent of them were on the official List of vital medicines (the list of medicines approved by the Government of the Russian Federation for the purpose of state regulation of prices for medicines).[2][19] By 2023, the portfolio expanded up to 250 names of drugs while the share of vital medicines in it remained at 80 percen.[17]

Production facilities

The Group produces medicines at a large Biochemist enterprise in Saransk. Its subsidiary Berakhim owns a pharmaceutical production in Obninsk (near Moscow).[17] A small part of the drugs (including areplivir) were also produced in 2021 at the facilities of Ozon LLC.[20]

In 2023, an agreement was signed with the government of Moscow on the establishment of a pharmaceutical production in the capital of Russia.[21]

ESG

In 1994, with the support of today's subsidiary Promomed, JSC Biokhimik, the Biokhimik-Mordovia football club was created, which existed until 2004 and in 2005 was transformed into the FC Mordovia Saransk.[22]

In October 2022, Promomed Group published its first ever ESG Report (environmental, social, and corporate governance).[23][24]

References

  1. ↑ Ооо Промомед Дм
  2. 1 2 3 "Pyotr Belyi:"Producing substances is just as important as mastering space"" Петр Белый: «Производить субстанции так же важно, как осваивать космос». Vedomosti (in Russian). Interviewed by Deryabina, Anna. 19 August 2021.
  3. ↑ "Promomed // Pharmaceutical company" Промомед // Фармацевтическая компания. PHARMPROM (Directory) (in Russian). 23 September 2020.
  4. 1 2 "Promomed Rus LLC" ООО «ПРОМОМЕД РУС». Medvestnik (Directory) (in Russian). Bionica Digital LLC.
  5. ↑ "The PRIMAVERA Study: Reduxine Safety Monitoring in Patients With Alimentary Obesity". U.S. Department of Health and Human Services, National Institutes of Health, National Library of Medicine, and National Center for Biotechnology Information. ClinicalTrials.gov. 4 August 2014. Archived from the original on 2021-10-25.
  6. ↑ "BRIEF-Biokhimik announces changes in shareholding structure". Reuters. 12 October 2016.
  7. ↑ "Promomed". TAdviser (Directory). 2023.
  8. ↑ Попов, Игорь; Ломская, Татьяна; Ганжур, Елена (6 September 2021). "The 20 best pharmaceutical companies in Russia — 2021. Forbes rating // 6. JSC "Biochemist"" 20 лучших фармкомпаний России — 2021. Рейтинг Forbes // 6. АО «Биохимик». Forbes (in Russian).
  9. ↑ Зотикова, Валентина (21 June 2019). "Saransk Biochemist Plant to launch production of 150 new medicines" Саранский завод "Биохимик" наладит выпуск 150 новых лекарств. Rossiyskaya Gazeta (in Russian). Saransk.
  10. ↑ ""Биохимик" поставляет продукцию в страны Персидского залива и Латинской Америки" [Biochemist supplies products to the countries of the Persian Gulf and Latin America]. Столица С (in Russian). 5 February 2019.
  11. ↑ "Russia Clears Two Coronavirus Drugs for Pharmacy Sale". The Moscow Times. 23 September 2020.
  12. ↑ "Russia-developed COVID-19 drug to start production in December". Nepal News. ANI. 13 November 2021.
  13. ↑ Limited liability company "PROMOMED DM", exchange-traded bond (RU000A102LB5)
  14. ↑ Limited liability company "PROMOMED DM", exchange-traded bond (RU000A1053T9)
  15. ↑ "Promomed Pharmaceutical Company placed the second issue of bonds for 1.5 billion rubles" Фармкомпания "Промомед" разместила второй выпуск бондов на 1,5 млрд рублей. TASS (in Russian). 30 July 2021.
  16. ↑ "Promomed DM increased the volume of the bond program from 1.5 to 5 billion rubles" "Промомед ДМ" увеличила объем программы облигаций с 1,5 до 5 млрд рублей. Finmarket (in Russian). 21 July 2022.
  17. 1 2 3 "Promomed bought a controlling stake in Berakhim from the wife of its founder" «Промомед» выкупил у супруги своего основателя контрольную долю в «Берахиме». Vedomosti (in Russian). 12 January 2023.
  18. ↑ "Promomed Group has registered a broad-spectrum antibiotic". GxP News. 16 July 2022. Retrieved 25 November 2023.
  19. ↑ "State Register of Medicines : Biochemist" Государственный реестр лекарственных средств. State Register of Medicines (Data base) (in Russian). 2023. Retrieved 10 October 2023.
  20. ↑ "The second line of production of medicines "Ozon Pharm" was opened in Togliatti" Вторую линию производства лекарств "Озон Фарм" открыли в Тольятти. TASS (in Russian). 25 October 2021.
  21. ↑ "The second line of production of medicines "Ozon Pharm" was opened in Togliatti" The SEZ "Technopolis Moscow" will create the production of innovative medicines. TASS (in Russian). 14 June 2023.
  22. ↑ "Igor Shinkarenko" Игорь Шинкаренко. PFC Krylia Sovetov Samara (in Russian). 15 January 2007.
  23. ↑ "Promomed Group has published its first ESG reportfounder" ГК «Промомед» опубликовала свой первый ESG-отчет. Pharmaceutical Bulletin (in Russian). 13 October 2022.
  24. ↑ "PROMOMED GROUP 2021 ESG REPORT" (pdf). Promomed (Report). 2022. p. 100.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.